THE INTERNATIONAL PROGNOSTIC INDEX IS ASSOCIATED WITH OUTCOMES IN DIFFUSE LARGE B CELL LYMPHOMA AFTER CAR T CELL THERAPY

CD19-targeted chimeric antigen receptor T cells (CAR T cells) have shown excellent activity against relapsed and refractory (R/R) diffuse large B-cell lymphoma (DLBCL). CAR T cell therapy is associated with early toxicities, including cytokine release syndrome and neurotoxicity. The incidence and se...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Transplant Cell Ther
Hlavní autoři: Garcia-Recio, Marta, Wudhikarn, Kitsada, Pennisi, Martina, Alonso-Trillo, Rosalia, Flynn, Jessica, Shouval, Roni, Afuye, Aishat O., Silverberg, Mari Lynne, Batlevi, Connie W, Parastoo, Dahi, Devlin, Sean, Giralt, Sergio, Halton, Elizabeth, Ruiz, Josel, Maloy, Molly, Mead, Elena, Palomba, Lia, Santomasso, Bianca, Sauter, Craig S, Scordo, Michael, Gunjan, Shah, Perales, Miguel-Angel
Médium: Artigo
Jazyk:Inglês
Vydáno: 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8010220/
https://ncbi.nlm.nih.gov/pubmed/33781518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtct.2020.10.022
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky